Teether
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
Claims
We claim the ornamental design for a teether, as shown and described.
Referenced Cited
U.S. Patent Documents
3669117 | June 1972 | Herbst |
D286443 | October 28, 1986 | Thomson et al. |
D306071 | February 13, 1990 | Klitsner |
D357746 | April 25, 1995 | Sofia |
D569002 | May 13, 2008 | Roehrig |
D569003 | May 13, 2008 | Roehrig |
D640385 | June 21, 2011 | Roehrig et al. |
D658773 | May 1, 2012 | Chin et al. |
8214962 | July 10, 2012 | Rohrig |
20030176891 | September 18, 2003 | Frederic |
Patent History
Patent number: D712050
Type: Grant
Filed: Mar 27, 2013
Date of Patent: Aug 26, 2014
Assignee: Glaxo Group Limited (Brentford, Middlesex)
Inventors: Marcus Blachford (Warwick), Alex Brian (Surrey), Andrew Mitchell (Warwick), Simon Ritchie (Surrey)
Primary Examiner: Susan E Krakower
Assistant Examiner: Sydney R Buffalow
Application Number: 29/450,988
Type: Grant
Filed: Mar 27, 2013
Date of Patent: Aug 26, 2014
Assignee: Glaxo Group Limited (Brentford, Middlesex)
Inventors: Marcus Blachford (Warwick), Alex Brian (Surrey), Andrew Mitchell (Warwick), Simon Ritchie (Surrey)
Primary Examiner: Susan E Krakower
Assistant Examiner: Sydney R Buffalow
Application Number: 29/450,988
Classifications
Current U.S. Class:
Nipple, Pacifier Or Masticator (56) (D24/194)